Is MS a Buy? What to Consider in 2026
Short answer
The bull case for Morgan Stanley (MS) rests on Wealth management as a recurring-revenue engine: Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. Revenue (Full Year 2025) is ~$70.6 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Whether MS is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.
What's the case for buying MS?
Wealth management as a recurring-revenue engine
Wealth Management generated roughly 50 percent of total firm revenues in fiscal 2025, anchoring profitability with fee income tied to client assets rather than market transactions. The segment reported a 30 percent pre-tax margin in Q3 2025 and brought in $81 billion of net new assets in the same quarter. As client assets grow and fee-based flows compound, this segment acts as a structural earnings floor.
Capital-markets cycle recovery
Investment banking revenue surged 44 percent year over year in Q3 2025, driven by more completed mergers, more IPOs, and more fixed-income fundraising. Analysts expect continued recovery in advisory and underwriting fees as deal pipelines that were frozen during the rate-hike cycle are finally executed. A sustained M&A and IPO rebound would provide a meaningful uplift to the Institutional Securities segment on top of already-strong equities trading results.
Equities trading franchise momentum
Morgan Stanley's equities desk produced record results in recent quarters, with Q3 2025 equities revenues jumping 35 percent year over year to $4.12 billion, well above analyst estimates, and driven partly by record prime brokerage activity catering to hedge funds. This franchise has consistently ranked among the top two or three globally and benefits from scale, technology investment, and deep client relationships that are difficult for competitors to replicate quickly.
Scale in client assets and capital return
Total client assets across Wealth and Investment Management reached $9.3 trillion at year-end 2025, and the firm holds more than $400 billion in customer deposits. Following the 2026 stress tests, Morgan Stanley raised its quarterly dividend by 15 percent and announced a new $20 billion stock buyback program, signaling confidence in its capital position and its ability to return cash to shareholders while continuing to invest in the business.
What are the risks to MS?
A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally.
How is MS valued? (as of 2026-06-27)
- Revenue (Full Year 2025): ~$70.6 billion
- Net Income (Full Year 2025): ~$13.4 billion (approx., based on ~$10.21 EPS on ~1.58B diluted shares)
- EPS (TTM): ~$11.04
- P/E Ratio (TTM): ~19-20x
- Forward P/E: ~17.6x
- Market Capitalization: ~$334 billion
- Return on Tangible Common Equity (Full Year 2025): ~21.6%
- Annual Dividend Per Share: ~$4.00 (dividend yield ~1.9%)
Morgan Stanley's trailing P/E of roughly 19 to 20 times sits modestly above its own 5-year historical average of around 14 to 15 times, reflecting the market's recognition of the firm's successful shift toward more durable, fee-based earnings. The ROTCE of 21.6% for full-year 2025 demonstrates that the integrated-firm model is generating returns well above most peers' cost of equity, though sustaining that level depends on continued strength in both capital markets and wealth inflows. At a forward P/E of approximately 17.6 times, the stock is not priced as a deep-value name, meaning expectations for continued earnings growth are already embedded in the current price.
How do you decide if MS is a buy?
Rather than asking whether MS is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold MS indirectly through an index or sector ETF before adding more.
For the full picture, see the MS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about MS against your real portfolio and see your actual exposure before deciding.
The bottom line on MS
The bottom line: Morgan Stanley's story right now is Wealth management as a recurring-revenue engine, with revenue (full year 2025) at ~$70.6 billion. If you believe that narrative continues, the call is about sizing MS sensibly and checking overlap with what you own; if you doubt it (the risk: a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around MS with Walnut
Use Morgan Stanley as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is MS a good stock to buy right now?
+
The case for Morgan Stanley right now is Wealth management as a recurring-revenue engine, with revenue (full year 2025) at ~$70.6 billion. If you believe that thesis holds, MS is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does Morgan Stanley do?
+
Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees.
What are the main risks of MS?
+
A simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders. Regulatory capital requirements remain an ongoing headwind, with Basel-related rules potentially requiring the firm to hold more capital against trading and lending exposures, constraining returns. Morgan Stanley's stock also carries a beta above 1.0, meaning it tends to move more than the broader market in both directions, so sharp equity-market selloffs can produce outsized drawdowns. Finally, a structural decline in equity underwriting volumes over a prolonged period would disproportionately affect a firm that has historically ranked as a top equity underwriter globally.
What does Morgan Stanley do?
+
Morgan Stanley is a global financial services firm that operates across three main segments: Institutional Securities (investment banking, sales and trading, and prime brokerage for corporations and institutions), Wealth Management (advisory, brokerage, lending, and banking for individuals and families), and Investment Management (mutual funds, alternatives, and institutional strategies). The firm holds approximately $9.3 trillion in total client assets across its wealth and investment management businesses.
Is MS a good stock to buy right now?
+
Whether MS fits a portfolio depends on individual goals, time horizon, risk tolerance, and existing financial-sector exposure. The firm's fee-based wealth revenues provide more earnings stability than it had a decade ago, and it trades at roughly 19 to 20 times trailing earnings. Investors comfortable with financial-sector cyclicality and a beta above 1.0 tend to view the integrated model as a long-term compounder; others may find the valuation leaves limited margin of safety.
Does MS pay a dividend?
+
Yes. Morgan Stanley pays a quarterly cash dividend. Following the June 2026 stress tests, the firm raised its quarterly dividend by 15 percent. The annualized dividend stands at approximately $4.00 per share, implying a yield of roughly 1.9 percent at recent share prices. The firm also announced a new $20 billion share repurchase program alongside the dividend increase, reflecting its strong capital position.
Who are Morgan Stanley's main competitors?
+
Competition varies by segment. In investment banking and trading, Goldman Sachs and JPMorgan Chase are the primary rivals. In wealth management, UBS, Merrill Lynch, and Raymond James compete for clients and advisors. In asset management, Morgan Stanley faces BlackRock, Blackstone, and other alternative managers. Its E*TRADE platform competes with Schwab and Fidelity in the self-directed brokerage space.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell MS; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.